Supplemental Figure 8 shows the relationship between the Fraction of Genome Altered by UROMOL subgroups within the MSK cohort.
No takes yet. Share an insight, caveat, or question.
Damrauer et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: